Senzime AB (publ) (SNZZF)
USD 0.53
(0.0%)
USD 0.53
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 58.06 Million SEK | -4.46% |
| 2022 | 60.77 Million SEK | 152.8% |
| 2021 | 24.04 Million SEK | -12.72% |
| 2020 | 27.54 Million SEK | 14.45% |
| 2019 | 24.06 Million SEK | -19.1% |
| 2018 | 29.74 Million SEK | 16.33% |
| 2017 | 25.57 Million SEK | 4.63% |
| 2016 | 24.44 Million SEK | 1126.44% |
| 2015 | 1.99 Million SEK | -10.94% |
| 2014 | 2.23 Million SEK | 91.47% |
| 2013 | 1.16 Million SEK | -6.29% |
| 2012 | 1.24 Million SEK | -67.12% |
| 2011 | 3.79 Million SEK | -5.82% |
| 2010 | 4.02 Million SEK | -11.76% |
| 2009 | 4.56 Million SEK | -5.42% |
| 2008 | 4.82 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 73.5 Million SEK | 29.24% |
| 2024 Q1 | 56.87 Million SEK | -2.05% |
| 2023 Q4 | 58.06 Million SEK | -0.41% |
| 2023 FY | 58.06 Million SEK | -4.46% |
| 2023 Q3 | 58.3 Million SEK | -0.72% |
| 2023 Q2 | 58.72 Million SEK | 9.73% |
| 2023 Q1 | 53.51 Million SEK | -11.94% |
| 2022 Q3 | 274.08 Million SEK | 594.25% |
| 2022 Q4 | 60.77 Million SEK | -77.83% |
| 2022 FY | 60.77 Million SEK | 152.8% |
| 2022 Q2 | 39.48 Million SEK | 70.23% |
| 2022 Q1 | 23.19 Million SEK | -3.54% |
| 2021 Q4 | 24.04 Million SEK | 15.8% |
| 2021 Q1 | 22.24 Million SEK | -19.24% |
| 2021 Q2 | 22.69 Million SEK | 2.0% |
| 2021 Q3 | 20.76 Million SEK | -8.52% |
| 2021 FY | 24.04 Million SEK | -12.72% |
| 2020 Q4 | 27.54 Million SEK | 17.84% |
| 2020 Q3 | 23.37 Million SEK | 6.26% |
| 2020 Q1 | 21.56 Million SEK | -10.39% |
| 2020 FY | 27.54 Million SEK | 14.45% |
| 2020 Q2 | 21.99 Million SEK | 2.0% |
| 2019 FY | 24.06 Million SEK | -19.1% |
| 2019 Q3 | 23.26 Million SEK | -3.84% |
| 2019 Q4 | 24.06 Million SEK | 3.44% |
| 2019 Q1 | 25.98 Million SEK | -12.66% |
| 2019 Q2 | 24.19 Million SEK | -6.88% |
| 2018 Q2 | 26.13 Million SEK | 1.87% |
| 2018 Q4 | 29.74 Million SEK | 20.77% |
| 2018 Q1 | 25.65 Million SEK | 0.31% |
| 2018 FY | 29.74 Million SEK | 16.33% |
| 2018 Q3 | 24.63 Million SEK | -5.74% |
| 2017 Q2 | 23.8 Million SEK | 0.6% |
| 2017 FY | 25.57 Million SEK | 4.63% |
| 2017 Q3 | 24.68 Million SEK | 3.68% |
| 2017 Q1 | 23.66 Million SEK | -3.18% |
| 2017 Q4 | 25.57 Million SEK | 3.62% |
| 2016 Q1 | 2.2 Million SEK | 10.54% |
| 2016 Q2 | 27.42 Million SEK | 1144.75% |
| 2016 Q4 | 24.44 Million SEK | 0.44% |
| 2016 FY | 24.44 Million SEK | 1126.44% |
| 2016 Q3 | 24.33 Million SEK | -11.25% |
| 2015 Q4 | 1.99 Million SEK | -9.58% |
| 2015 Q2 | 2.13 Million SEK | 98.32% |
| 2015 Q1 | 1.07 Million SEK | -52.0% |
| 2015 FY | 1.99 Million SEK | -10.94% |
| 2015 Q3 | 2.2 Million SEK | 3.46% |
| 2014 Q3 | 1.25 Million SEK | 23.01% |
| 2014 Q4 | 2.23 Million SEK | 78.0% |
| 2014 FY | 2.23 Million SEK | 91.47% |
| 2014 Q2 | 1.02 Million SEK | 0.0% |
| 2014 Q1 | - SEK | -100.0% |
| 2013 Q1 | 2.53 Million SEK | 103.09% |
| 2013 Q2 | 2.53 Million SEK | 0.0% |
| 2013 FY | 1.16 Million SEK | -6.29% |
| 2013 Q4 | 1.16 Million SEK | 0.0% |
| 2012 Q2 | 1.24 Million SEK | 0.0% |
| 2012 Q4 | 1.24 Million SEK | 0.0% |
| 2012 FY | 1.24 Million SEK | -67.12% |
| 2011 FY | 3.79 Million SEK | -5.82% |
| 2011 Q2 | 3.75 Million SEK | 0.0% |
| 2011 Q4 | 3.79 Million SEK | 0.0% |
| 2010 Q4 | 4.02 Million SEK | 0.0% |
| 2010 Q2 | 4.12 Million SEK | 0.0% |
| 2010 FY | 4.02 Million SEK | -11.76% |
| 2009 Q4 | 4.56 Million SEK | 0.0% |
| 2009 FY | 4.56 Million SEK | -5.42% |
| 2008 FY | 4.82 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -192.292% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -2641.501% |
| Össur hf. | 688.8 Million USD | 91.57% |
| QHSLab, Inc. | 2.05 Million USD | -2722.733% |
| Wellstar International, Inc. | 55.99 Million USD | -3.705% |
| Össur hf. | 688.8 Million USD | 91.57% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -1869.411% |
| Aurora Spine Corporation | 6.65 Million USD | -772.694% |
| BrainsWay Ltd. | 15.31 Million USD | -279.163% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -249.309% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -26.661% |
| Vivos Inc. | 245 Thousand USD | -23599.613% |
| Kelyniam Global, Inc. | 1.01 Million USD | -5632.352% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -20967.507% |
| Zecotek Photonics Inc. | 5.86 Million USD | -889.417% |
| Avitar, Inc. | 11.59 Million USD | -400.839% |
| Nanomix Corporation | 14.81 Million USD | -291.941% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -261.089% |
| Theraclion SA | 13.01 Million EUR | -346.085% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -2765.995% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -1503.487% |
| Lombard Medical, Inc. | 53.79 Million USD | -7.94% |
| ALR Technologies Inc. | 24.5 Million USD | -136.948% |
| Stratec SE | 271.97 Million USD | 78.65% |
| Vycor Medical, Inc. | 4.31 Million USD | -1244.79% |
| Heart Tronics, Inc. | 1.09 Million USD | -5203.762% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 97.665% |
| VMS Rehab Systems, Inc. | 201.36 USD | -28836312.396% |
| NewCardio, Inc. | 6.01 Million USD | -865.714% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -960.548% |
| Ingen Technologies, Inc. | 5.7 Million USD | -916.981% |
| Odyssey Group International, Inc. | 6.61 Million USD | -778.213% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -2270.186% |
| Wellness Center USA, Inc. | 5.12 Million USD | -1033.153% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 11.478% |
| IR-Med Inc. | 634 Thousand USD | -9058.517% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -960.245% |
| Polarean Imaging plc | 2.58 Million USD | -2150.111% |
| United American Healthcare Corporation | 119 Thousand USD | -48694.118% |
| ECGI Holdings, Inc. | 11.94 Million USD | -386.292% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -2361.648% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -4285.627% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -3914.625% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -8469.013% |
| Urologix, Inc. | 12.64 Million USD | -359.23% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -976.062% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -584.531% |
| SS Innovations International, Inc. | 11.18 Million USD | -419.314% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -10951.853% |
| Smith & Nephew plc | 4.76 Billion USD | 98.781% |
| NIOX Group Plc | 9.8 Million USD | -492.373% |
| Fuse Medical, Inc. | 15.11 Million USD | -284.28% |
| Broncus Holding Corporation | 10.43 Million USD | -456.596% |
| Brain Scientific Inc. | 7.42 Million USD | -681.872% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -71.772% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -7212.226% |